Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fatol Arzneimittel is a specialized German pharmaceutical company based in Schiffweiler, primarily focused on the treatment of infectious diseases and urological conditions. The company is widely recognized as a leading provider of antitubercular medications, maintaining a comprehensive portfolio of essential drugs such as rifampicin, isoniazid, and pyrazinamide. Founded in 1950, Fatol has built a strong reputation for quality and reliability in the German healthcare market. In 2011, the company was acquired by Aristo Pharma GmbH, becoming an integral part of one of Germany's largest pharmaceutical groups. Today, Fatol continues to manufacture and distribute specialty medicines while benefiting from the extensive production and distribution network of the Aristo Pharma Group.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fatol Arzneimittel.